[ Price : $8.95]
FDA removes a partial clinical hold against ProJenX and its Study PRO-101, a hybrid Phase 1 clinical trial evaluating prosetin in ...[ Price : $8.95]
FDA approves Roches cobas malaria test for use on the cobas 6800/8800 Systems to aid healthcare professionals in reducing potentia...[ Price : $8.95]
In the wake of this weeks U.S. Supreme Court oral arguments on the abortion drug mifepristone, a new Axios/Ipsos poll finds that m...[ Price : $8.95]
FDA releases a final guidance entitled Providing Regulatory Submissions in Electronic Format: IND Safety Reports.[ Price : $8.95]
FDA extends by three months its review of an Applied Therapeutics NDA for govorestat (AT-007) for treating classic galactosemia.[ Price : $8.95]
FDA publishes a draft guidance to help with animal studies for dental bone grafting devices submitted with a 510(k).[ Price : $8.95]
FDA approves Akeibas Vafseo to treat anemia in some adults with chronic kidney disease.[ Price : $8.95]
Aldeyra Therapeutics says it will conduct a dry eye chamber clinical trial of its reproxalap in hopes of resubmitting an NDA for t...